Keywords: ANOVA; Analysis of variance; AT; Austria; BIC; Bayesian information criterion; CH; Switzerland; CHF; Swiss franc; CRE; Community renewable energy; ElWOG; Elektrizitätswirtschafts- und -organisationsgesetz, Electricity Act in Austria; EnG; Energiegesetz,
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: bNAbs; broadly neutralizing antibodies; hbNAbs; human broadly neutralizing antibodies; bnmAbs; broadly neutralizing monoclonal antibodies; Env; envelope; Technology; Monoclonal antibody; Phage/yeast display; Neutralization; Single-cell sorting;
Keywords: BDS; bulk drug substance; BPL; β-propiolactone; cGMP; current good manufacturing practices; DENV; dengue virus; DP; drug product; Env; envelope protein; FFA; focus forming assay; GLP; good laboratory practices; H2O2; hydrogen peroxide; IVRP; in vitro rel
Keywords: ZIKV; Zika virus; C; Capsid; Env; Envelope; NS proteins; nonstructural; Ctr; Centrosome; Mito; Mitochondria; ER; Endoplasmic reticulum; Golgi; Golgi apparatus; ICC; Immunocytochemistry; WB; western blot; Zika virus (ZIKV); Capsid; Envelope; Nonstructural
Keywords: lymphedema; pathophysiology; primary; secondary; skin; APCD; advanced pneumatic compression device; BCRL; breast cancer-related lymphedema; ENV; elephantiasis nostras verrucosa;
Keywords: Aircraft emissions; Environmental tax; Aviation fuel tax; Jet fuel; Global warming; BMF; Federal Ministry of Finance (Germany); BOJ; Bank of Japan; DEA; Danish Energy Agency; ENV; Ministry of the Environment Japan; EPA; Environmental Protection Agency; IA
Keywords: ACC; acceleration; CCT IR; total amount of dirt particles in the process medium - Fe; ENV; Envelope acceleration; FFT; Fast Fourier Transform; gE; Unit of Envelope Acceleration; HFD; High Frequency Detection; PLP; Percent of Large Particles; PPM; Parts
Keywords: Wound catheter; Interfascial location; NRS; Morphine consumption; Catéter incisional; Localización interfascial; ENV; Consumo de morfina;
Keywords: Ac4ManNAz; peracylated azidomannosamine; ASLV; Avian Sarcoma and Leukosis Virus; Env; viral envelope glycoprotein; SiaNAz; N-azidosialic acid; VSV; Vesicular Stomatitis Virus; YFP; yellow fluorescent protein; Retrovirus; Vesicular stomatitis virus; Metabo
Keywords: CAEPs; cortical auditory evoked potentials; Cz; central zero; Fz; frontal zero; SNR; signal to noise ratio; ENV; envelope; TFS; temporal fine structure; NH; normal hearing; SNHL; sensorineural hearing loss; TEN; threshold equalising noise; ANOVA; analysis
Keywords: BDNF; Brain derived neurotrophic factor; CD14; cluster of differentiation 14; ENV; envelope; GWAS; genome wide association studies; GAG; group specific antigen; HERVs; human endogenous retroviruses; HPA; hypothalamic pituitary adrenal; IGF2; insulin-like
Keywords: SD; sustainable development; SQOL; social-quality of life; ECON; economic development; ENV; environmental protection; SDI; sustainable development index; DM1; a member from local authorities; DM2; a member from neighborhood community; DM3; a member from N
Keywords: ABR; auditory brainstem response; AEP; auditory evoked potential; ENV; envelope; SAM; sinusoidally amplitude modulated; SNHL; sensorineural hearing loss; TFS; temporal fine structure;
Keywords: ASI; anthesis-silking interval; ENV; environment; GY; grain yield; HI; harvest index; IPAR; intercepted photosynthetically active radiation; KN; kernel number; KW; kernel weight; LA; leaf area; LAI; leaf area index; NIWA; National Institute of Water and A
Keywords: CGR; crop growth rate; CGRES; crop growth rate between emergence and silking; CGRss; crop growth rate between silking and silage harvest; CRM; comparative relative maturity; ENV; environment; GY; grain yield; HI; harvest index; IPAR; intercepted photosynt
Keywords: AICD; activation-induced cell death; AIDS; acquired immunodeficiency syndrome; APC; antigen presenting cells; CCF; cell-cell fusion; CNS; central nervous system compartment; DAE; differential-algebraic equations; ENV; Env-CD4 cross-linking mediated apop
Modulation of the NF-κB signaling pathway by the HIV-2 envelope glycoprotein and its incomplete BST-2 antagonism
Keywords: HIV; human immunodeficiency virus; Env; envelope glycoprotein; BST-2; Bone Marrow Stromal Cell Antigen 2; NF-κB; nuclear factor kappa-light-chain-enhancer of activated B cells; IκBs; inhibitors of κB proteins; IKKs; IκB kinases; HIV; HIV-2; Env; Envel
Design, display and immunogenicity of HIV1 gp120 fragment immunogens on virus-like particles
Keywords: Protein stability; Immune focusing; Neutralizing antibodies; Vaccine; Nanoparticles; CD4bs; CD4 binding site; OD; outer domain; Env; envelope glycoprotein; CP; capsid protein; VLPs; virus-like particles; PBS; phosphate buffer saline; Cys; cysteine; SMCC;
The involvement of plasmacytoid cells in HIV infection and pathogenesis
Keywords: AIDS; Acquired Immune Deficiency Syndrome; APC; antigen presenting cells; CDP; common DC progenitor; DCs; dendritic cells; Env; envelope; HEV; high endothelial venules; HIV-1; Human Immunodeficiency Virus type 1; IDO; indoleamine-pyrrole 2,3-dioxygenase;
Early Env-specific CTLs effectively suppress viral replication in SHIV controller macaques
Keywords: SHIV; Acute infection; Function; CTL; Env;
Exposure of the HIV-1 broadly neutralizing antibody 10E8 MPER epitope on the membrane surface by gp41 transmembrane domain scaffolds
Keywords: MPER; membrane-proximal external region; TMD; transmembrane domain; Env; HIV-1 envelope glycoprotein; MD; molecular dynamics; bNAb; broadly neutralizing antibody; CDR-H3; complementarity-determining region three of the heavy chain; HC; heavy chain; WT; wi
Finding synergies for 3Rs - Toxicokinetics and read-across: Report from an EPAA partners' Forum
Keywords: Physiologically-based kinetic (PBK) modelling; Hazard and risk assessment; Weight-of-evidence (WoE); Threshold of toxicological concern (TTC); In vitro to in vivo extrapolation (IVIVE); Integrated approach for testing and assessment (IATA); Absorption; Di
5-Hydroxytyrosol inhibits HIV-1 replication in primary cells of the lower and upper female reproductive tract
Keywords: HIV-1; 5-Hydroxytyrosol; Microbicide; Human cervical tissue explants; Endometrium-associated leukocytes; CD38; CTE; cervical tissue explants; EAL; endometrium-associated leukocytes; Env; envelope; FBS; fetal bovine serum; FRT; female reproductive tract; I
Establishment of an avian leukosis virus subgroup A-resistant cell line
Keywords: avian leukosis virus subgroup A (ALV-A); env; DF-1/A cell line; diagnostic tool;
Lepidopteran species have a variety of defence strategies against bacterial infections
Keywords: AMPs; antimicrobial peptides; PGRPs; peptidoglycan recognition proteins; PO; phenoloxidase; OD; optical density; ROS; reactive oxygen species; ENV; S. marcescens ssp. marcescens Bizio; ENT; S. marcescens ssp. marcescens db11; 6-Tox; Bacterial infection; C
Monocyte-lymphocyte fusion induced by the HIV-1 envelope generates functional heterokaryons with an activated monocyte-like phenotype
Keywords: HIV-1; human immunodeficiency virus type 1; MFI; mean fluorescence intensity; FcγR; receptor for the Fc portion of IgG; Env; HIV-1 envelope protein; SIV; simian immunodeficiency virus; PMA; phorbol 12-myristate 13-acetate; DiI; 1,1'-dioctadecyl-3, 3,3â
Enhancing the sensitivity of Dengue virus serotype detection by RT-PCR among infected children in India
Keywords: DENV; dengue virus; RT-PCR; reverse transcription-polymerase chain reaction; C-prM; capsid-premembrane; Env; envelope; NS1; Non-structural protein-1; Dengue virus; Serology; Detection; Serotyping; RT-PCR; Comparison;
HIV-Specific B Cell Frequency Correlates with Neutralization Breadth in Patients Naturally Controlling HIV-Infection
Keywords: HIV; human immunodeficiency virus; Env; HIV envelope protein; cART; combined antiretroviral therapy; EC; elite controller; IgG; immunoglobulin G; (n)Ab; (neutralizing) antibody; ADCC; antibody-dependent cell-mediated cytotoxicity; CTL; cytotoxic T cell; T
Lipid raft-like liposomes used for targeted delivery of a chimeric entry-inhibitor peptide with anti-HIV-1 activity
Keywords: Chimeric peptide; Entry inhibitor peptide; Lipid raft-like liposomes; Targeted delivery; HIV-1; CHOL; cholesterol; CLSM; confocal laser scanning microscopy; CP; chimeric peptide; DMEM; Dulbecco's Modified Eagle's Medium; DMSO; dimethyl sulfoxide; DPPC; 1,
Genetic characterization of highly pathogenic H5 influenza viruses from poultry in Taiwan, 2015
Keywords: KU1; Crane/Kagoshima/KU1/2014; KU13; Crane/Kagoshima/KU13/2014; HA; hemagglutinin; NA; neuraminidase; Tonghai/5; A/chicken/Tonghai/5/2014 (H5N1); GD01; A/duck/Guangdong/GD01/2014 (H5N6); Buan2; A/duck/Korea/Buan2/2014 (H5N8); Gochang1; A/duck/Korea/Gochan
Analgesia basada en infusión continua de anestésico local a nivel interfascial tras cirugÃa de colon laparoscópico: Ensayo clÃnico
Keywords: Cateterincisional; Localización interfascial; ENV; Consumo de morfina; Wound catheter; Interfascial location; NRS; Morphine consumption;
A high throughput Cre-lox activated viral membrane fusion assay identifies pharmacological inhibitors of HIV entry
Keywords: HIV-1; Gag; Cre recombinase; Drug screening; Virus entry; Env; Viral membrane fusion;
HIV-1 adaptation to low levels of CCR5 results in V3 and V2 loop changes that increase envelope pathogenicity, CCR5 affinity and decrease susceptibility to Maraviroc
Keywords: CCR5; chemokine receptor; Env; Envelope; MVC; Maraviroc; DMEM; Dulbecco׳s Modified Eagles medium; RT; Reverse Transcriptase; HIV; Human Immunodeficiency Virus; AIDS; Acquired Immune Deficiency Syndrome; FPR; False Positive Ratio; HIV; AIDS; Co-receptor;
Binding of inferred germline precursors of broadly neutralizing HIV-1 antibodies to native-like envelope trimers
Keywords: Broadly neutralizing antibodies; Germline; HIV-1; Env; SOSIP; Vaccine;
Stoichiometric parameters of HIV-1 entry
Keywords: HIV-2; gp120; Env; Entry; Relative infectivity; CD4; CCR5; CXCR4;
Assembly and characterization of gp160-nanodiscs: A new platform for biochemical characterization of HIV envelope spikes
Keywords: HIV; AIDS; Env; gp160; Glycoprotein; Lipid nanodiscs; Membrane protein;
Defense-in-depth by mucosally administered anti-HIV dimeric IgA2 and systemic IgG1 mAbs: Complete protection of rhesus monkeys from mucosal SHIV challenge
Keywords: Ab; antibody; mAb; monoclonal antibody; nmAb; neutralizing monoclonal antibody; ADCC; antibody-dependent cellular cytotoxic activity; AID50; 50% animal infectious doses; C1; first conserved region; CTL; cytotoxic T lymphocyte; dIgA; dimeric IgA; Env; enve
Prime/boost immunization with HIV-1 MPER-V3 fusion construct enhances humoral and cellular immune responses
Keywords: Env; envelope; Gp; glycoprotein; bNAbs; broadly neutralizing antibodies; MPER; membrane-proximal external region; APCs; antigen presenting cells; CPPs; cell penetrating peptides; NLS; nuclear localization sequence; HIV; MPER-V3; DNA vaccine; Peptide vacci
Comparison of multiple adjuvants on the stability and immunogenicity of a clade C HIV-1 gp140 trimer
Keywords: HIV-1; Env; Adjuvants;
Progress in HIV-1 vaccine development
Keywords: HIV-1; vaccine; T cells; B cells; broadly neutralizing antibodies; ADCC; Antibody-dependent cellular cytotoxicity; BCR; B-cell antigen receptor; bnAb; Broad neutralizing antibody; Env; Envelope; gp; Glycoprotein; HC; Heavy chain; HCDR3; Immunoglobulin thi
RRE-dependent HIV-1 Env RNA effects on Gag protein expression, assembly and release
Keywords: HIV-1; Env; Gag; RNA export; RRE;
Proliferation and copy number variation of BEL-like long terminal repeat retrotransposons within the Diabrotica virgifera virgifera genome
Keywords: A; alanine; BAC; bacterial artificial chromosome; BRSD; Brookings, South Dakota population; cad; cadherin gene; CDD; conserved domain database; CNV; copy number variation; D; aspartic acid; DOC; depth of coverage; E; glutamic acid; env; envelope gene; EST
Multi-parameter exploration of HIV-1 virus-like particles as neutralizing antibody immunogens in guinea pigs, rabbits and macaques
Keywords: HIV; Vaccine; Antibody; Neutralization; VLPs; gp120; gp41; Env;
Immunogen design for HIV-1 and influenza
Keywords: HIV-1; human immunodeficiency virus-1; Env; envelope; PNGS; potential N-linked glycosylation sites; bNAb; broadly neutralizing antibody; GL; germline; T/F; Transmitted/Founder virus; MPER; membrane proximal external region; OD; Outer domain; CD4bs; CD4 bi
Evaluation of the automatic editing tool RECall for HIV-1 pol and V3 loop sequences
Keywords: AA; amino acid; ART; antiretroviral therapy; env; envelope gene; EQA; external quality assessment; FPR; false positive rate; HIV-1; human immunodeficiency virus type 1; NNRTI; non-nucleoside reverse transcriptase inhibitor; NRTI; nucleoside reverse transc
Utility of the Sindbis replicon system as an Env-targeted HIV vaccine
Keywords: VEEV; Venezuelan equine encephalitis virus; SFV; Semliki forest virus; SIN; Sindbis virus; nsPs; non-structural proteins; PKR; dsRNA-dependent protein kinase R; 2â²5â²OAS; 2â²5â²-linked oligoadenylate synthetase; Env; HIV-1 envelope protein; SIV; simi
Cell-cell transmission allows human T-lymphotropic virus 1 to circumvent tetherin restriction
Keywords: APC; antigen presenting cell; ATM; acute T-cell lymphoma; ELISA; enzyme-linked immunosorbent assay; Env; envelope; GPI; glycosyl-phosphatidylinositol; HAM/TSP; HTLV-1 associated myelopathy/tropical spastic paraparesis; HIV; human immunodeficiency virus; H
Effects of sensorineural hearing loss on temporal coding of narrowband and broadband signals in the auditory periphery
Keywords: AN; auditory nerve; CF; characteristic frequency; ENV; envelope; FM; frequency modulation; SPL; sound pressure level; SR; spontaneous rate; TFS; temporal fine structure;
Designing of novel antigenic peptide cocktail for the detection of antibodies to HIV-1/2 by ELISA
Keywords: ELISA; enzyme linked immunosorbent assay; Ag; antigen; Ab; antibody; HIV; human immuno-deficiency virus; HPLC; high pressure liquid chromatography; AIDS; acquired immuno deficiency syndrome; env; envelope; gp; glycoproteins; C; cysteine bridge; TMB; 3,3,5
The magnitude of HIV-1 resistance to the CCR5 antagonist maraviroc may impart a differential alteration in HIV-1 tropism for macrophages and T-cell subsets
Keywords: HIV-1; Maraviroc; Resistance; T-cell; Macrophage; Tropism; Env; gp120